Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel deals blow to ViroPharma drug, recommends reduced testing for generic versions
FDA panel deals blow to ViroPharma drug, recommends reduced testing for generic versions
FDA panel deals blow to ViroPharma drug, recommends reduced testing for generic versions
Submitted by
admin
on August 5, 2009 - 8:05am
Source:
Yahoo/AP
News Tags:
FDA
ViroPharma
generics
Vancocin
Headline:
FDA panel deals blow to ViroPharma drug, recommends reduced testing for generic versions
Do Not Allow Advertisers to Use My Personal information
